Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Frédéric Stauffer

Frédéric Stauffer, Basel CH

Patent application numberDescriptionPublished
200902644063-METHYL-IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES - The invention relates to compounds of formula (I) and salts thereof10-22-2009
20090286779PYRAZOLOPYRIMIDINES AS LIPID KINASE INHIBITORS - The invention relates to novel—at least 3,5-disubstituted-pyrazolo[1,5-a]pyrimidines of the formula I,11-19-2009
201003117141H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS - The invention relates to the use of 1H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone compounds.12-09-2010
201003176571H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES - The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone derivatives; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone derivatives.12-16-2010

Frédéric Stauffer, Reinach CH

Patent application numberDescriptionPublished
200802620211H-Imidazoquinoline Derivatives as Prote In Kinase Inhibitors - The invention relates to imidazoquinolines of formula (I) for use in the treatment of protein kinase dependent diseases; pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease; novel imidazoquinolines; and a process for the preparation of the novel imidazoquinolines.10-23-2008
201000565581,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-2-ONES AS LIPID KINASE INHIBITORS - The invention relates to novel organic compounds of formula (I)03-04-2010

Patent applications by Frédéric Stauffer, Reinach CH

Frédéric Stauffer, Hesingue FR

Patent application numberDescriptionPublished
200902588822,4-Substituted Quinazolines as Lipid Kinase Inhibitors - The invention relates to compounds of the formula I,10-15-2009
20090318410IMIDAZOPYRIDAZINES AS LIPID KINASE INHIBITORS - The invention relates to novel compounds of the formula I,12-24-2009
20100041662Heterocyclic compounds as antiinflammatory agents - A compound of Formula Ia or Ib in free or salt or solvate form, where R02-18-2010

Frédéric Stauffer, Basel CH

Patent application numberDescriptionPublished
201003117141H-IMIDAZO[4,5-c]QUINOLINONE COMPOUNDS - The invention relates to the use of 1H-imidazo[4,5-c]quinolinone compounds and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone compounds for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone compounds to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone compounds, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone compounds; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone compounds.12-09-2010
201003176571H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES - The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c]quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H-imidazo[4,5-c]quinolinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c]quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1H-imidazo[4,5-c]quinolinone derivatives; and a process for the preparation of the novel 1H-imidazo[4,5-c]quinolinone derivatives.12-16-2010

Frédéric Stauffer, Reinach CH

Patent application numberDescriptionPublished
201000565581,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-2-ONES AS LIPID KINASE INHIBITORS - The invention relates to novel organic compounds of formula (I)03-04-2010

Frédéric Stauffer, Hesingue FR

Patent application numberDescriptionPublished
20090318410IMIDAZOPYRIDAZINES AS LIPID KINASE INHIBITORS - The invention relates to novel compounds of the formula I,12-24-2009
20100041662Heterocyclic compounds as antiinflammatory agents - A compound of Formula Ia or Ib in free or salt or solvate form, where R02-18-2010